2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association, European Heart Journal, vol.4, issue.1, pp.2719-2766, 2012. ,
DOI : 10.1161/CIRCEP.110.955393
Prevalence of Diagnosed Atrial Fibrillation in Adults, JAMA, vol.285, issue.18, pp.2370-2375, 2001. ,
DOI : 10.1001/jama.285.18.2370
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study, Heart, vol.86, issue.5, 2001. ,
DOI : 10.1136/heart.86.5.516
Atrial fibrillation management: a prospective survey in ESC Member Countries, European Heart Journal, vol.26, issue.22, pp.2422-2456, 2005. ,
DOI : 10.1186/1471-2261-4-18
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol, 2009. ,
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol, pp.1006-1029, 2007. ,
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study, The American Journal of Medicine, vol.113, issue.5, pp.359-64, 2002. ,
DOI : 10.1016/S0002-9343(02)01236-6
Outcome parameters for trials in atrial fibrillation: executive summary, Eur Heart J, 2007. ,
Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy, European Heart Journal, vol.110, issue.5646, pp.2125-2157, 2008. ,
DOI : 10.1126/science.1090349
Quality of Life in Patients with Atrial Fibrillation: A Systematic Review, The American Journal of Medicine, vol.119, issue.5, pp.448-449, 2006. ,
DOI : 10.1016/j.amjmed.2005.10.057
Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence. Stroke and thromboembolism in atrial fibrillation ,
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study, European Heart Journal, vol.4, issue.12, pp.1500-1510, 2012. ,
DOI : 10.1161/CIRCOUTCOMES.110.958108
Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N Engl J Med, vol.360, issue.20, pp.2066-78, 2009. ,
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study, BMJ, vol.344, issue.may30 3, p.3522, 2012. ,
DOI : 10.1136/bmj.e3522
Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation, Chest, vol.141, issue.1, pp.147-53, 2012. ,
DOI : 10.1378/chest.11-0862
New oral anticoagulant drugs in cardiovascular disease, Thrombosis and Haemostasis, vol.104, issue.1, pp.49-60, 2010. ,
DOI : 10.1160/TH09-05-0327
Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation, Journal of the American College of Cardiology, vol.60, issue.8, pp.738-784, 2012. ,
DOI : 10.1016/j.jacc.2012.03.019
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes, Journal of the American College of Cardiology, vol.59, issue.16, pp.1413-1438, 2012. ,
DOI : 10.1016/j.jacc.2012.02.008
Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate, Thromb Haemost, 2012. ,
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice, Thrombosis and Haemostasis, vol.107, issue.5, pp.838-885, 2012. ,
DOI : 10.1160/TH11-10-0718
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA) Thromb Haemost, pp.868-76, 2011. ,
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects, Circulation, vol.124, issue.14, pp.1573-1582, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.111.029017
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban, Thrombosis and Haemostasis, vol.108, issue.2, 2012. ,
DOI : 10.1160/TH12-03-0179
Dabigatran etexilate ??? a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity, Thrombosis and Haemostasis, vol.103, issue.6, pp.1116-1143, 2010. ,
DOI : 10.1160/TH09-11-0758
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion, Circulation, vol.123, issue.2, pp.131-137, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.110.977546
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of longterm anticoagulant therapy (RE-LY) trial. Circulation, pp.2363-72, 2011. ,
Safety and Outcomes following Thrombolytic Treatment in Stroke Patients Who Had Received Prior Treatment with Anticoagulants, Cerebrovascular Diseases, vol.363, issue.3, pp.231-240, 2012. ,
DOI : 10.1016/S0140-6736(04)15692-4
Outpatient treatment of recurrent atrial fibrillation with the " pill-in-the-pocket " approach: practical aspects]. Ital Heart J Suppl Off J Ital Fed Cardiol, pp.335-375, 2005. ,
Outpatient Treatment of Recent-Onset Atrial Fibrillation with the ???Pill-in-the-Pocket??? Approach, New England Journal of Medicine, vol.351, issue.23, pp.2384-91, 2004. ,
DOI : 10.1056/NEJMoa041233
Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial, The Lancet, vol.360, issue.9342, pp.1275-1284, 2002. ,
DOI : 10.1016/S0140-6736(02)11315-8
Facilitating Transthoracic Cardioversion of Atrial Fibrillation with Ibutilide Pretreatment, New England Journal of Medicine, vol.340, issue.24, pp.1849-54, 1999. ,
DOI : 10.1056/NEJM199906173402401
Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study. Cardiovasc Drugs Ther Spons Int Soc Cardiovasc Pharmacother, pp.31-40, 2003. ,
Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: A placebo-controlled study, Journal of the American College of Cardiology, vol.28, issue.3, pp.700-706, 1996. ,
DOI : 10.1016/0735-1097(96)00230-6
Management of atrial fibrillation in emergency medicine. French society of emergency medicine (SFMU) guidelines with the contribution of the French society of cardiology (SFC), Annales fran??aises de m??decine d'urgence, vol.5, issue.4, pp.260-79, 2015. ,
DOI : 10.1007/s13341-015-0554-3